Independent Director 2025 Annual Performance Report
To all shareholders and shareholder representatives:
As an independent director of Qianjiang Yong'an Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company"), in 2025, I strictly adhered to the "Company Law," "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Listed Company Self-Regulatory Supervision Guidelines No. 1—Normative Operation of Main Board Listed Companies," and other relevant laws and regulations, as well as the "Company Articles of Association" and "Work System for Independent Directors." I diligently and faithfully performed my duties, actively attended relevant company meetings, conscientiously reviewed various proposals, fully exercised my functions as an independent director, and effectively protected the legitimate rights and interests of the Company and all shareholders, especially small and medium shareholders. The report on my performance in 2025 is as follows:
I. Basic Information
(I) Work Experience
I, Zhao Chunxiang, born in 1978, am a Chinese national with no permanent overseas residency. I hold a Ph.D. in Accounting and am the Associate Dean and Professor of the Department of Financial Management at Zhongnan University of Economics and Law. I am also a member of the Seventh Council of the China Cost Research Association, Director of the China Economic and Accounting Supervision Research Center, and a non-practicing member of the Chinese Institute of Certified Public Accountants. I have served as a visiting scholar at Curtin University in Australia and National Chengchi University in Taiwan. I previously served as an Assistant Lecturer, Lecturer, and Associate Professor at Zhongnan University of Economics and Law. I am currently a Professor at Zhongnan University of Economics and Law and concurrently serve as an independent director for Wuhan Ruike Fiber Optic Laser Technology Co., Ltd. and Hubei Dongbei Special Motor Group Co., Ltd. Since June 2021, I have served as an independent director and Chairman of the Audit Committee of the Company.